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Abstract
Background: Health research is increasing in Africa, but most resources are currently chanelled towards infectious 
diseases and health system development. While infectious diseases remain a heavy burden for some African countries, 
non-communicable diseases (NCDs) account for more than half of all deaths globally and WHO predicts 27% increase 
in NCDs in Africa over the next decade. We present findings of a European-Africa consultation on the research agenda 
for NCDs.
Methods: A workshop was held in Yaoundé, Cameroon, organized by the Network for the Coordination and 
Advancement of Sub-Saharan Africa-European Union Science and Technology Cooperation (CAAST-Net). Drawing on 
initial presentations, a small expert group from academic, clinical, public-health and administrative positions 
considered research needs in Africa for cardiovascular disease, cancer and diabetes.
Results: Research in Africa can draw from different environmental and genetic characteristics to understand the 
causes of the disease, while economic and social factors are important in developing relevant strategies for prevention 
and treatment. The suggested research needs include better methods for description and recording, clinical studies, 
understanding cultural impacts, prevention strategies, and the integrated organisation of care. Specific fields proposed 
for research are listed.
Conclusions: Our paper contributes to transparency in the process of priority-setting for health research in Africa. 
Although the European Union Seventh Framework Research Programme prioritises biomedical and clinical research, 
research for Africa should also address broader social and cultural research and intervention research for greatest 
impact. Research policy leaders in Africa must engage national governments and international agencies as well as 
service providers and research communities. None can act effectively alone. Bringing together the different 
stakeholders, and feeding the results through to the European Union research programme is a valuable contribution of 
CAAST-Net.
Introduction
The workshop to develop research priorities on non-
communicable diseases (NCDs) in Africa was held in
Yaoundé, Cameroon, 4-5 November 2009. It was orga-
nized by the Network for the Coordination and Advance-
ment of Sub-Saharan Africa-European Union Science and
Technology Cooperation (CAAST-Net) and hosted by
the Institut de Recherche pour le Développement (IRD).
This paper describes the process and findings of the
workshop as a contribution to research development in
Africa and for transparency in European policy-making.
Developing research cooperation
CAAST-Net was established with funding through the
European Union's Seventh Research Framework Pro-
gramme (FP7) to advance research cooperation between
Africa and Europe[1]. The four-year project, which
started in 2008, supports Africa-Europe dialogue across a
broad range of policy areas related to science and tech-
nology, and includes the including identification of spe-
cific research topics for support under the research
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Framework ProgrammeResearch FP7. It forms one of a
group of projects advancing cooperation between Europe
and Africa supported by the EU and is led by the Associa-
t i o n  o f  C o m m o n w e a l t h  U n i v e r s i t i e s  o n  b e h a l f  o f  t h e
International Science and Innovation Unit of the UK gov-
ernment. CAAST-Net maps African research issues of
mutual interest for Europe, seeks a consensual approach
from participants, and addresses broad themes for subse-
quent elaboration. The three main criteria to prioritise
choices are: 1) enabling conditions (that capacity has to
exist); 2) strategic imperatives - international policy sup-
port, for example in The New Partnership for Africa's
Development (NEPAD) [2]; and 3) mutual benefit for
Europe and Africa. In May 2009, the first panel consid-
ered research on energy, while later seminars address
urban transport and social sciences research. Outputs
from each seminar are specific researchable topics, while
the broader outcome is strategic research cooperation
between the two continents.
Health research in Africa
Developments over the past decade have raised the pro-
file of health research in Africa. The Abuja Declaration
and Plan of Action from the African Summit on Roll Back
Malaria in 2000 catalysed concern for both interventions
and research for health. NEPAD, created in 2001 under
the auspices of the Organisation of African Unity, recogn-
ises the contribution of health in supporting economic
development in Africa. The Joint EU-Africa Strategy,
adopted at the Lisbon EU-Africa Summit in 2007, com-
prises eight thematic partnerships, including one for Sci-
ence, Information Society and Space. The Global
Ministerial Forum on Research for Health in Bamako,
Mali in 2008 affirmed the importance for Africa of health
research, and particularly for research on non-communi-
cable diseases [3].
Non-communicable diseases in Africa
The epidemiological transition and resulting rise in non-
communicable diseases gives prominence to non-com-
municable diseases (including cardiovascular disease -
heart disease and stroke - diabetes and some cancers),
which together now account worldwide for up to 60% of
deaths, and almost half of all 'premature' deaths [4].
WHO predicts that NCD deaths globally will increase by
17% over the next decade, with the greatest increase in
the African region (27%) [5]. Yet in sub-Saharan Africa,
governments, donors and research-funders have chan-
nelled most resources into infectious diseases, especially
the trio of HIV, malaria and tuberculosis; and initiatives
such as the European and Developing Countries Clinical
Trials Partnership (EDCTP) have been focused on treat-
ment and healthcare services for these infections rather
than the needs and opportunities for interventions
against NCDs, through clinical trials, changing lifestyles
and public policy.
Recent favourable developments in support of address-
ing NCDs include the WHO Global Strategy for the Pre-
vention and Control of Noncommunicable Diseases [5]
and the establishment by WHO, the World Bank, the
World Economic Forum, and three international NGOs
(the World Heart Federation, International Diabetes Fed-
eration and the International Union against Cancer), of a
global NCDs network (NCDnet) to spread initiatives on
NCDs [6]. The network will join health-care and preven-
tive approaches, and also enable research on interven-
tions at primary care level [7].
Determining NCD research priorities
There is a limited literature on non-communicable dis-
ease research priorities in developing countries. Unwin et
al [8] reported conclusions of 'discussions over several
years' between clinicians in UK and two African coun-
tries. They recommended clinical research in three broad
areas - surveillance, treatment and prevention - without a
basic sciences biomedical approach. Daar et al [4] drew
on views from experts and representatives from interna-
tional organisations and research agencies. Publishing in
Nature, they proposed 39 topics for research across six
broad socio-political areas: raising public awareness,
enhancing policies, modifying risk factors, engaging busi-
ness and communities, mitigating impacts of poverty and
urbanisation, and reorienting health systems. Ebrahim
and Smeeth [9] summarised existing literature on NCDs
relevant to low and middle-income countries, but also
recommended that research within individual countries,
rather than simply drawing from world scientific litera-
ture, is crucial to changing government agendas and poli-
cies.
European Union health research programme
The European Union Seventh Research Framework Pro-
gramme runs from 2007 to 2013. It has four broad sub-
programmes: Cooperation (thematic research); Ideas
(researcher-driven proposals); Capacities (supporting
structures); and Marie Curie (supporting individuals).
Health is the second best-resourced of the thematic calls
within the Capacities programme, distributing around
seven hundred million Euros a year. Calls for research are
made annually. As well as researchers within the EU, and
the 'associated states' which also contribute financially to
the programme, research collaboration is encouraged
with countries across the world. Some parts of the call are
focused on international cooperation with specific geo-
graphical regions and countries beyond the EU. For the
first time in 2009, topics for cooperation with Africa in
three thematic areas - health, food and environment -McCarthy et al. Health Research Policy and Systems 2010, 8:13
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were launched as a coordinated joint call. Further calls
are anticipated for the period 2010-2013.
Methods
The CAAST-net consultation brought together a small
group of experts, selected from African and European
countries and with a range of disciplines, for a two-day
meeting in Yaoundé, Cameroon during 4-5 November
2009. Prior to the consultation, experts and stakeholders
were asked to submit short abstracts on potential
research issues, and 17 of these were received and consid-
ered within the consultation. The objective of the meet-
ing was to recommend broad areas for research for the
three NCDs (cardiovascular disease, cancer and diabetes)
i d e n t i f i e d  a s  h a v i n g  p a r t i c u l a r  r e l e v a n c e  f o r  A f r i c a -
Europe collaboration, and for integrated approaches to
these NCDs. The process of consultation in the workshop
did not seek to be exhaustive of knowledge and research
initiatives on the topics. Consideration of the specific
proposals submitted in advance served to initiate discus-
sion, resulting in the identification of broad topics to be
considered and further elaborated for inclusion in further
calls under the health theme. This report records the sug-
gestions and discussions of the group over the two days.
We have added references which record the background
information rather than a full literature review.
Results
Research can use the different environmental and genetic
characteristics present in Africa to better understand the
causes of the disease, and help develop strategies relevant
for prevention and treatment.
Cardiovascular disease
African aspects of cardiovascular diseases were consid-
ered to include the wide population distribution of hyper-
tension, and impacts including premature stroke, heart
and renal failure. The burden of cardiovascular disease in
Africa is growing, and contributing conditions, such as
diabetes and obesity, are also increasing rapidly. There is
an urgent need for more comprehensive and representa-
tive data to define better this burden across Africa and for
studies on disease control.
While known risk factors have an important place,
there is no equivalent of the Framingham longitudinal
study providing data about populations and factors of dis-
ease progression for Africa. Areas of further investigation
could include salt sensitivity and arterial stiffness - which
may have genetic components. Since malnutrition rather
than dietary excess continues to be a pressing problem in
rural Africa, low birth weight and sub-optimal develop-
ment may be an important determinant of cardiovascular
diseases in later age for people moving to towns and cities
and taking up western lifestyles.
Cultural, ethnographic and geographical analyses are
important, since there may be differences between west-
ern and African concepts of health and disease. Cultural
attitudes towards obesity, for example, may have marked
differences within and between continents, such that in
some societies obesity may be seen as a sign of wealth or a
feature of beauty.
There is a lack of representative information within
countries, and insufficient information on differences
between countries. There is a need for the development
of structures for gathering information, networks to share
data and support analysis, and better use of information
to provide health policy makers with the evidence base
for developing and adopting new approaches. At local
level, systems developed for HIV treatment and monitor-
ing could form the basis for the development of shared
disease and treatment registries. These data, when linked
to differences in cultures, are also of great interest to
social scientists.
Areas of concern include how to organise the health
system to provide an effective response to the challenges
posed by cardiovascular disease, the evaluation of cost-
effectiveness of different means of care delivery, and the
provision of the related social support programmes
needed. Developments need to be adapted to the popula-
tion, including for example innovations in diagnostic
tests, outreach support through tele-medicine and
improved access to medicaments, with the value deter-
mined by cost-effectiveness studies.
The discussion indicated the following research topics:
Studies assessing the effectiveness of prevention, e.g.
promoting health and changing lifestyles
Studies explaining variations in disease incidence -
assessing the role of risk factors (e.g. low birth
weight), genomics, and cultural aspects
Studies aimed at improving data on incidence and
outcomes of treatment and care
Developing networks for data collection, sharing and
analysis
Studies of how varying cultures mediate in treatment
effectiveness
Comparing disease risk and occurrence in Africans in
Africa and Africans who are migrants to Europe
Studies of ways of improving diagnosis, including
ways of providing advice at a distance
Cancer
While WHO's leadership has helped to increase attention
to cancer worldwide, there has been significant progress
in raising the profile of cancer in Africa, including the
systematic description of what is currently known [10]. In
addition to cancers which are common in both Europe
and Africa, e.g. breast, colon, lung and prostate, there are
significant impacts in Africa of cancers strongly associ-McCarthy et al. Health Research Policy and Systems 2010, 8:13
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ated with virus infection, e.g. cancer of cervix and Kaposi
sarcoma, and concern for skin cancer in albinos.
CARISA [11] reported the 'landscape' of cancer
research of South Africa. Cancer research support
includes data management, diagnostics (biomarkers,
genomic profiling, imaging techniques), prevention,
treatment, and palliation and social aspects. But their
main areas proposed for research included molecular
carcinogenesis, genetic and molecular epidemiology, and
therapeutic development.
However, while there is much interest in the links
between genetics and cancer, Africa has a diverse gene
pool, limiting the feasibility of epidemiological studies.
Moreover, as yet no-one has identified human protein
markers, and proteomics is beyond the financial
resources of most African countries.
There is an urgent need to improve diagnostic services,
including the evaluation of diagnostic innovations such
'telepathology' (as there are very few pathologists in
Africa) and to improve treatment services, including the
provision of common anti-cancer drugs and morphine
for palliation.
Cultural factors for investigation include the possible
protective effects of diet against cancer (e.g. drinking
Rooibos tea in South Africa) and plants (e.g. maize as a
factor in the lower prevalence of colon cancer among
black than among white South Africans).
Knowledge is needed to support ministries of health in
developing evidence-based policies for the implementa-
tion of interventions which are widely available or are
being widely introduced in Europe but are not yet avail-
able in Africa. For example, cost-benefit and health poli-
tics studies are needed on the impact of human papilloma
virus vaccination and cervical cancer screening pro-
grammes on cervical cancer prevention. Public demand
also needs consideration.
The discussion indicated the following research topics:
Studies of aetiology, e.g. epidemiological investigation
of variations in incidence of common cancers, differ-
ences of environment, viruses, lifestyle (including
diets), and genetic markers
Studies on the effective organisation of services,
including improved diagnosis (e.g. telepathology for
identification of lymphoma) and treatment (e.g. cost-
effectiveness and equity of access in provision of che-
motherapy and radiotherapy), and palliative care (e.g.
pain control)
Occupational cancers - studies of ethical and legal
issues, protection of workers, mines, issues of planta-
tions
Scoping study of emerging diagnostics, including pro-
teomics
Studies of better data collection, including cancer reg-
istration, management and assessment of impact
Effectiveness and cost-effectiveness of prevention
strategies: vaccines, tobacco, diet, alcohol, informa-
tion and education for lifestyle change. Policy
research to inform decision-makers choosing differ-
ent prevention strategies
Psychological and cultural approaches to cancer as a
disease, and towards end-of-life care.
Evidence for policy-makers to decide between differ-
ent models of cancer, including assessment of equity
of access and outcome
Diabetes
There are estimated to be 12 million people with type 2
diabetes in Africa, and the numbers are growing by 1 mil-
lion every two years. Type 2 diabetes in European coun-
tries is due to increases in obesity. Similarly, explanations
f o r  t h e  r i s i n g  p r e v a l e n c e  o f  d i a b e t e s  i n  s u b - S a h a r a n
Africa concern obesity through lifestyle changes due to
globalisation and urbanisation, although in Africa it is as
yet the more affluent sections of society who are becom-
ing more sedentary and overweight. One participant
reported that a study in Cameroon showed a prevalence
of type 2 diabetes of about 6%, with a prevalence of
impaired glucose tolerance ('borderline diabetes") of up
to 1 - 3%. More comprehensive and representative data in
Africa are needed.
A critical issue for epidemiological studies is in defining
standards for diagnosis. Reference values from western
countries may not necessarily be the same for Africa. For
diabetes there is debate whether HbA1C is superior to
fasting blood sugar and glucose tolerance test, because of
its relatively high cost and the potential difficulty in its
interpretation in the presence of haemoglobinopathies
and glucose-6-phosphate dehydrogenase (G6PD) defi-
ciency. The suggestion that differentiation between type
1 and type 2 diabetes is less clear cut in Africa needs fur-
ther study.
Research may investigate whether there are characteris-
tics for people who develop diabetes which are specific to
Africa, such as unique genetic polymorphisms and inter-
actions with the environment (epigenetic phenomena).
For example, in parts of Africa, such as around the great
lakes, the soil contains much iron and there are clinical
reports of unusual forms of diabetes in patients who are
not obese and relatively young, which may be associated
with pancreatic iron overload. Nutritional factors are
important, including the 'double burden of malnutrition' -
the relationship between malnutrition in maternal and
early infancy periods and later dietary excess and lack of
physical activity, leading to diabetes.
Optimal diabetes control and management can
decrease the risk of end-organ damage. Research is
needed on improving the primary care response to the
needs of people with diabetes, including cost-effectiveMcCarthy et al. Health Research Policy and Systems 2010, 8:13
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ways of recognising organ damage and improving clinical
management, and new approaches to complications such
as diabetic foot disease. There are examples of a few pre-
ventive and care programmes, e.g. in certain sites in
Nigeria and the Democratic Republic of the Congo, but
these are in the private healthcare sector. Half a million
people worldwide have chronic diabetic kidney disease.
The numbers affected by renal disease in Africa and the
financial implications for diagnosis and treatment need to
be further explored.
The discussion indicated the following research topics:
Coordinated studies of prevalence and trends of dia-
betes in different settings.
Studies to evaluate implementation of a structured
approach to diagnosis and treatment, with improved
data collection on diagnosis and treatment outcomes
to inform better service delivery.
Studies on improving access to diagnosis and care,
with care delivery closer to the patient, e.g. in com-
munity settings and through enhanced role of non-
medical staff.
Assessment of effectiveness of early detection of end-
organ damage (for burden of disease and service plan-
ning, e.g. foot care problems)
Studies of dietary transition from rural malnutrition
to different diets in urban settings, the role of mater-
nal malnutrition, extent and mechanisms of insulin-
resistance, and barriers and resilience of communities
for prevention.
Biotechnical approaches to aetiology - genetics, resis-
tance, blood markers, animal models.
Urbanisation - environments affecting human behav-
iours - causing diabetes and the potential for alterna-
tive urban settings
Studies on provision of affordable diagnosis, case-
detection and screening
Integrated approaches to NCDs
In addition to the research topics identified for each spe-
cific NCD, research is also relevant to the NCDs collec-
tively, since they share common risk factors, interactions,
and similarities in approaches to prevention and care.
Common risk factors including such as smoking, obe-
sity, alcohol and hypertension contribute to cardiovascu-
lar disease and its complications, as well as cancer and
diabetes. Integrated delivery of health services for pre-
vention and care, as well as multisectoral policies for pre-
vention, can contribute to reduction of all of these
diseases.
Since important social and cultural perspectives may be
relevant across different NCDs, studies of prevention and
clinical management should address NCDs as a group.
This can be more efficient, avoiding duplication of effort:
for example, developing a standard approach to registra-
tion and follow-up of patients, and developing policies for
prevention based on shared risk factors. The cost of phar-
maceuticals, especially in long-term care, imposes a seri-
ous burden on African countries, and competes in budget
with other health priorities including finance for
research.
The discussion indicated the following research topics:
Measurement of prevalence and trends over time of
common shared risk factors of NCDs in different set-
tings in Africa, e.g. urban, semi-urban and rural
Studies of management of NCDs in primary care set-
tings, including records systems, diagnosis and man-
agement protocols, and drug procurement
Studies on policies and practice for lifestyle changes
to meet shared risk factors in NCDs, including physi-
cal activity, smoking, improved diet and decreased
alcohol intake
Studies on health systems and quality of care delivery,
e.g. human resources, financing, procurement of
drugs and supplies, and organisation of health facili-
ties
Discussion
Research on non-communicable diseases in Africa is 'a
priority, not a distraction' [9]. While malnutrition and
famine remain the predominant concerns in rural areas,
and infectious diseases continue to impose an heavy
buruden in some African countries, NCDs are emerging
as the major health threat of middle-income countries
and are increasingly important in urban areas of even the
poorest countries. Just as control of infectious diseases
through environmental means assists the whole popula-
tion, so also action on behavioural disease determinants -
smoking, diet, physical activity - will also assist broad sec-
tions of the population. It may be argued that the deter-
minants of late-onset diabetes are very similar to those
for cardiovascular disease, while a third major field of
morbidity and mortality should be considered for preven-
tion research - road accident trauma, which is rising rap-
idly as mobility in Africa increases. But research linking
transport and health is not a priority area for the Euro-
pean Union, nor are these topics as yet prioritised
together for Africa.
The workshop noted biological and laboratory issues,
clinical and epidemiological features, and also research
on the organisation of prevention and care, reflecting the
broad backgrounds of the participating panel. The pro-
cess did not seek to be exhaustive of knowledge and
research initiatives on the topics, but rather to extend
broadly and indicate topics for calls whereby more
focused areas can be proposed. One referee for this paper,
however, noted a lack of interventional topics - "ie trying
out new types of intervention at public health or clinicalMcCarthy et al. Health Research Policy and Systems 2010, 8:13
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levels, and how such intervention/treatments should be
organised": these could include initial pilot studies, out-
come clinical trials and Ministry-level projects as experi-
mental interventions. There is also a strong rationale for
considering the NCDs collectively, since they share com-
mon risk factors and common interactions, i.e. between
obesity, smoking and exercise, and diabetes, hypertension
and cardiovascular disease. The delivery of health service
interventions for prevention and care, and the often mul-
tisectoral policies aimed at preventive measures, contrib-
ute to a reduction of all of these diseases [5]. It is
therefore necessary to consider not only research topics
relevant to specific NCDs, but also research topics which
represent a joint approach to the different NCDs
together.
Funding for research through the EU Research Frame-
work Programme has grown rapidly in the past decade,
because policymakers have urged a link between invest-
ment in research, innovation and economic improve-
ment. Health research has also risen in priority,
competing with agricultural, transport and IT research.
The Seventh Research Framework Programme has
encouraged participation of researchers across the world
as partners in collaborative projects and programmes,
and the 2010 calls for research related to Africa in three
fields - health, agriculture and transport - were presented
together with a total budget of over €20 m (although
evaluated within the existing disciplines). The annual
calls in FP7 are usually for 3-year proposals by a consor-
tium of partners in both Europe and Africa, with total
budgets around €3 m. CAAST-Net, itself funded through
a competitive call in FP7, provides a mechanism for
researchers to share their interests, to suggest priorities
to the programme, and to develop collaborations. This
present paper, reporting a CAAST-Net meeting, seeks to
add transparency to this process.
Specific recommendations for research themes at the
workshop were consolidated, developed into potential
call texts, and distributed for further consultation before
submission to the European Commission. The European
research framework programme has a multitude of
inputs, and an annual cycle which iterates between exter-
nal advice and internal programme development. Euro-
pean member states have a strong influence through the
programme committees, although in the health field
national research councils give more support to labora-
tory and biomedical topics than to public-health research
[12]. Cooperation between European and African part-
ners is possible under the EU research framework pro-
gramme across a range of topics of mutual interest and
benefit.
While as yet the European Union Research Framework
Programme prioritises biomedical and clinical research,
research for Africa should address broader social and cul-
tural research for greatest impact. Research on non-com-
municable diseases in Africa can contribute both to
African development and also to better understanding of
these diseases. Policy responses to NCD disease research
in Africa must engage national governments and interna-
tional agencies as well as service providers and research
communities. None can act effectively alone,. Bringing
together the different stakeholders was a valuable contri-
bution of CAAST-Net, and the workshop proposals will
be among inputs to inform calls for joint European-Afri-
can health research in the coming years.
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